[1]
“Cross-docking and molecular dynamic studies to achieve the potent antiviral HIV-1 nonnucleoside reverse transcriptase inhibitors”, Sci. Ess. J, vol. 39, no. 2, pp. 23–37, Nov. 2023, Accessed: Oct. 23, 2026. [Online]. Available: https://ejournals.swu.ac.th/sej/article/view/15577